These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 21770780)

  • 1. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
    Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A GPR18-based signalling system regulates IOP in murine eye.
    Caldwell MD; Hu SS; Viswanathan S; Bradshaw H; Kelly ME; Straiker A
    Br J Pharmacol; 2013 Jun; 169(4):834-43. PubMed ID: 23461720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists.
    Hudson BD; Beazley M; Szczesniak AM; Straiker A; Kelly ME
    J Pharmacol Exp Ther; 2011 Dec; 339(3):757-67. PubMed ID: 21885619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol.
    Qiao Z; Kumar A; Kumar P; Song ZH
    Exp Eye Res; 2012 Jul; 100():59-64. PubMed ID: 22580290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles.
    Su EN; Kelly ME; Cringle SJ; Yu DY
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4029-37. PubMed ID: 26098470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
    Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The In Vivo Effects of the CB
    Cairns EA; Szczesniak AM; Straiker AJ; Kulkarni PM; Pertwee RG; Thakur GA; Baldridge WH; Kelly MEM
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):582-590. PubMed ID: 28719234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
    García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits.
    Hodges LC; Reggio PH; Green K
    Ophthalmic Res; 1997; 29(1):1-5. PubMed ID: 9112260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.
    Offertáler L; Mo FM; Bátkai S; Liu J; Begg M; Razdan RK; Martin BR; Bukoski RD; Kunos G
    Mol Pharmacol; 2003 Mar; 63(3):699-705. PubMed ID: 12606780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2.
    Song ZH; Slowey CA
    J Pharmacol Exp Ther; 2000 Jan; 292(1):136-9. PubMed ID: 10604940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quest for endothelial atypical cannabinoid receptor: BK
    Bondarenko AI; Panasiuk O; Drachuk K; Montecucco F; Brandt KJ; Mach F
    Vascul Pharmacol; 2018 Mar; 102():44-55. PubMed ID: 29355732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topically administered CB(2)-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits.
    Laine K; Järvinen K; Järvinen T
    Life Sci; 2003 Jan; 72(7):837-42. PubMed ID: 12479982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.
    Oltmanns MH; Samudre SS; Castillo IG; Hosseini A; Lichtman AH; Allen RC; Lattanzio FA; Williams PB
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):104-15. PubMed ID: 18201139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cannabinoid antinociception: synergy with spinal sites.
    Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
    Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
    McHugh D; Hu SS; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB
    BMC Neurosci; 2010 Mar; 11():44. PubMed ID: 20346144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens.
    Pertwee RG; Thomas A; Stevenson LA; Maor Y; Mechoulam R
    Neuropharmacology; 2005 Jun; 48(8):1139-46. PubMed ID: 15910889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.
    Kreutz S; Koch M; Böttger C; Ghadban C; Korf HW; Dehghani F
    Glia; 2009 Feb; 57(3):286-94. PubMed ID: 18837048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.